Jin Yao | Decision Sciences | Best Researcher Award

Dr. Jin Yao | Decision Sciences | Best Researcher Award

Associate Chief Physician at West China Hospital of Sichuan University, China

Dr. Jin Yao, M.D., Ph.D., serves as the Associate Chief Physician and Deputy Director of the Department of Radiology at West China Hospital, Sichuan University, China. With over two decades of experience, Dr. Yao has established himself as a leading expert in the imaging evaluation of urinary system diseases, particularly prostate cancer and non-clear cell renal carcinoma. His innovative work integrates advanced radiological techniques such as radiomics and artificial intelligence to enhance diagnostic accuracy and patient outcomes. Dr. Yao has authored numerous impactful publications in high-impact journals, showcasing his dedication to advancing medical imaging. His contributions bridge clinical practice and research, positioning him as a pioneer in his field.

Professional Profile

Education

Dr. Jin Yao completed his M.D. in Imaging and Nuclear Medicine at Sichuan University in 2001. Building upon this foundation, he pursued a Ph.D. in the same field at the same institution, graduating in 2009. His academic journey at one of China’s most prestigious universities has equipped him with an in-depth understanding of imaging science, enabling him to address complex clinical challenges. His dual degrees highlight a commitment to combining clinical expertise with rigorous scientific inquiry.

Professional Experience

Dr. Yao began his professional career in 2001 as a Radiologist at West China Hospital, Sichuan University. Over the years, he has risen to become the Associate Chief Physician and Deputy Director of the Department of Radiology, reflecting his clinical excellence and leadership skills. His role involves managing complex radiological cases, mentoring younger colleagues, and leading research projects. Dr. Yao’s two decades of service have been instrumental in establishing West China Hospital as a center of excellence in diagnostic imaging and research.

Research Interests

Dr. Yao’s research focuses on the imaging evaluation of urinary system diseases, with a particular emphasis on non-clear cell renal carcinoma and prostate cancer. He is deeply involved in advancing multiparametric magnetic resonance imaging (mpMRI), radiomics, and artificial intelligence applications in medical imaging. His studies aim to improve diagnostic precision, reduce unnecessary procedures, and optimize treatment strategies. Dr. Yao’s innovative work contributes to the evolution of radiology as a tool for personalized medicine.

Research Skills

Dr. Yao possesses advanced expertise in multiparametric imaging, radiomics-based analysis, and the development of predictive models using artificial intelligence. His skills include quantitative imaging analysis, machine learning application, and contrast-enhanced CT interpretation. He is proficient in designing and conducting clinical studies, statistical data analysis, and collaborative interdisciplinary research. Dr. Yao’s technical proficiency and innovative approach make him a leader in translating imaging research into clinical practice.

Awards and Honors

While Dr. Yao’s profile does not list specific awards, his academic and professional accomplishments, coupled with his contributions to peer-reviewed journals, highlight his recognition within the radiology community. His role as Deputy Director of Radiology and his publications in high-impact journals such as British Journal of Radiology and Insights into Imaging underscore his influence in the field. Further achievements in grant funding and mentorship are potential avenues for additional recognition.

Conclusion

Dr. Jin Yao is a highly accomplished researcher with a solid track record in radiology, particularly in the imaging evaluation of urinary system diseases. His contributions to radiomics and predictive modeling in cancer imaging are commendable, and his extensive publication record underscores his research productivity. To maximize his competitiveness for the Best Researcher Award, highlighting leadership roles, mentorship, grant achievements, and broader research impact areas could further solidify his candidacy. Overall, he is a strong contender for the award based on his significant contributions to medical imaging research.

Publication Top Notes

  1. The accuracy and quality of image-based artificial intelligence for muscle-invasive bladder cancer prediction
    Authors: He, C., Xu, H., Yuan, E., Yao, J., Song, B.
    Year: 2024
    Journal: Insights into Imaging, 15(1), 185.
  2. Patients with ASPSCR1-TFE3 fusion achieve better response to ICI-based combination therapy among TFE3-rearranged renal cell carcinoma
    Authors: Zhao, J., Tang, Y., Hu, X., Zeng, H., Sun, G.X.
    Year: 2024
    Journal: Molecular Cancer, 23(1), 132.
  3. Development and validation of a predictive model based on clinical and MpMRI findings to reduce additional systematic prostate biopsy
    Authors: Cheng, X., Chen, Y., Xu, J., Yao, J., Song, B.
    Year: 2024
    Journal: Insights into Imaging, 15(1), 3.
  1. Subspecialized medical team mode facilitates radiology resident training
    Authors: Zhao, Y., Chen, Y., Yao, J., Hu, N., Lui, S.
    Year: 2024
    Journal: iRADIOLOGY, 2(5), 469–481.
  2. Application of Magnetic Resonance Imaging Report Combined With VI-RADS Bi-Parametric and Multi-Parametric Scoring Systems in Bladder Cancer Diagnosis
    Authors: Xu, H., Chen, Y., Ye, L., Song, B., Yao, J.
    Year: 2024
    Journal: Journal of Sichuan University. Medical Science Edition, 55(5), 1071–1077.
  3. Memory/Active T-Cell Activation Is Associated with Immunotherapeutic Response in Fumarate Hydratase–Deficient Renal Cell Carcinoma
    Authors: Chen, J., Hu, X., Zhao, J., Zeng, H., Sun, G.
    Year: 2024
    Journal: Clinical Cancer Research, 30(11), 2571–2581.
  1. Radiomics-based quantitative contrast-enhanced CT analysis of abdominal lymphadenopathy to differentiate tuberculosis from lymphoma
    Authors: Shen, M.-T., Liu, X., Gao, Y., Jiang, L., Yao, J.
    Year: 2024
    Journal: Precision Clinical Medicine, 7(1), pbae002.
  2. Corrigendum: Radiomic machine learning and external validation based on 3.0T mpMRI for prediction of intraductal carcinoma of prostate with different proportion
    Authors: Yang, L., Li, Z., Liang, X., Yao, J., Song, B.
    Year: 2024
    Journal: Frontiers in Oncology, 14, 1401121.
  3. The Value of Radiological Imaging in Assessing Extrarenal Fat and Renal Vein Invasion in Renal Cell Carcinoma
    Authors: Ma, J., Yuan, E., Chen, Y., Yao, J., Song, B.
    Year: 2024
    Journal: Current Medical Imaging, 20, e15734056243669.
  4. Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the Prostate
    Authors: Zhao, J., Xu, N., Zhu, S., Zeng, H., Sun, G.
    Year: 2024
    Citations: 6
    Journal: Cancer Research, 184(1), 154–167.